Financhill
Sell
45

CRSP Quote, Financials, Valuation and Earnings

Last price:
$56.43
Seasonality move :
-15.72%
Day range:
$54.93 - $56.67
52-week range:
$30.04 - $63.68
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.66x
Volume:
2.5M
Avg. volume:
3.4M
1-year change:
-2.56%
Market cap:
$4.9B
Revenue:
$35M
EPS (TTM):
-$4.52

Earnings Data

Next earnings date for CRSP
Aug 05
2025
Most recent earnings per share
-$1.58
Missed by $0.30
(May 6/2025)
Consensus Estimate
-$1.28
(May 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CRSP Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 $13M -- -- -$1.30 --
08/05/2025 Q2 $6.4M -- -- -$1.44 --
05/06/2025 Q1 $6M -- -$1.58 -$1.28 -$0.30
02/11/2025 Q4 $7.3M $35M -$0.44 -$1.19 $0.75
11/05/2024 Q3 $7.1M -- -$1.01 -$1.40 $0.39
08/05/2024 Q2 $13.6M -- -$1.49 -$1.42 -$0.07
05/08/2024 Q1 $26.5M -- -$1.43 -$1.46 $0.03
02/21/2024 Q4 $123.1M $200M $1.13 $0.05 $1.08
11/06/2023 Q3 -- -- -$1.41 -$1.95 $0.54
08/07/2023 Q2 -- -- -$0.98 -$2.10 $1.12
05/08/2023 Q1 -- -- -$0.67 -$1.64 $0.97
02/21/2023 Q4 -- -- -$1.41 -$2.27 $0.86
11/01/2022 Q3 -- -- -$2.24 -$2.24 -$0.00
08/08/2022 Q2 -- -- -$2.40 -$2.21 -$0.19
05/09/2022 Q1 -- -- -$2.32 -$1.97 -$0.35
02/16/2022 Q4 -- -- -$1.84 -$1.78 -$0.06
11/03/2021 Q3 -- -- -$1.67 -$1.76 $0.09
07/29/2021 Q2 -- -- $9.44 $3.12 $6.32
04/27/2021 Q1 -- -- -$1.51 -$1.47 -$0.04
02/16/2021 Q4 -- -- -$1.52 -$1.28 -$0.24
10/28/2020 Q3 -- -- -$1.32 -$1.19 -$0.13
07/27/2020 Q2 -- -- -$1.30 -$0.99 -$0.31
04/28/2020 Q1 -- -- -$1.15 -$1.04 -$0.11
02/12/2020 Q4 -- -- $0.51 $0.05 $0.46
10/28/2019 Q3 -- -- $2.40 $1.79 $0.61
07/29/2019 Q2 -- -- -$1.01 -$0.90 -$0.11
04/29/2019 Q1 -- -- -$0.93 -$0.90 -$0.03
02/25/2019 Q4 -- -- -$0.92 -- --
11/07/2018 Q3 -- -- -$1.07 -- --
08/07/2018 Q2 -- -- -$0.82 -- --
05/08/2018 Q1 -- -- -$0.62 -- --
03/08/2018 Q4 -- -- $0.01 -- --
11/08/2017 Q3 -- -- -$0.62 -- --
08/10/2017 Q2 -- -- -$0.56 -- --
03/31/2017 Q1 -- -- -$0.54 -- --
12/31/2016 Q4 -- -- $0.43 -- --
09/30/2016 Q3 -- -- -$0.37 -- --
06/30/2016 Q2 -- -- -$0.43 -- --
03/31/2016 Q1 -- -- -$0.29 -- --
12/31/2015 Q4 -- -- -$0.42 -- --
09/30/2015 Q3 -- -- -$0.22 -- --

CRISPR Therapeutics AG Earnings Questions

  • How Much did CRISPR Therapeutics AG Generate in Revenue Last Quarter?

    CRISPR Therapeutics AG reported -- worth of top line sales in its most recent quarter.

  • Did CRISPR Therapeutics AG Beat Earnings Last Quarter?

    CRISPR Therapeutics AG announced earnings per share of -$1.58 which represents a miss of analyst forecast a -$1.28 per share.

  • Is CRISPR Therapeutics AG Profitable?

    CRISPR Therapeutics AG reported -$57.5M that represents -$0.67 per share over the last quarter.

  • What is the Analyst Consensus for CRISPR Therapeutics AG EPS Next Year?

    CRISPR Therapeutics AG's earnings are forecast to decrease from -$4.34 per share to -$5.12 per share next year representing a decrease of -23.5%.

  • When is CRISPR Therapeutics AG's Earnings Date?

    CRISPR Therapeutics AG's next earnings date is August 5, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Oklo Stock Double?
Will Oklo Stock Double?

Oklo (NYSE: OKLO) is only a year removed from its SPAC‑enabled debut,…

Why a $5 Stock Is Suddenly a Cash Machine
Why a $5 Stock Is Suddenly a Cash Machine

If you stopped tracking Grab Holdings (NASDAQ: GRAB) after its 2021 SPAC…

Is Roku Stock Undervalued Now?
Is Roku Stock Undervalued Now?

At roughly $89 a share, Roku (NASDAQ: ROKU) trades for barely…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Alerts

Buy
55
INKT alert for Jul 15

MiNK Therapeutics [INKT] is down 36.03% over the past day.

Sell
48
NEGG alert for Jul 15

Newegg Commerce [NEGG] is down 26.42% over the past day.

Buy
77
VBTX alert for Jul 15

Veritex Holdings [VBTX] is up 19.56% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock